FDA Letter API

Med Shop Total Care Inc.

Letter data

Company
Med Shop Total Care Inc.
Recipient
Jennifer D. Yoakum | Co-Owner and Pharmacist-In-Charge | Med Shop Total Care Inc. | 479 E. Loop 281 | Longview | , | TX | 75605-7939 | United States | jyoakum@medshoptotalcare.com
Issue date
2023-10-11
Posted date
Not available
FDA office
Office of Pharmaceutical Quality Operations, Division II
Subject
Not available
Product
Drugs
CMS ID
628182
Reference number
Not available
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER Med Shop Total Care Inc. MARCS-CMS 628182 — October 11, 2023 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: VIA Electronic Mail Product: Drugs Recipient: Recipient Name Jennifer D. Yoakum Recipient Title Co-Owner and Pharmacist-In-Charge Med Shop Total Care Inc. 479 E. Loop 281 Longview , TX 75605-7939 United States jyoakum@medshoptotalcare.com Issuing Office: Office of Pharmaceutical Quality Operations, Division II United States Dear Ms. Yoakum: The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letters (Case #581309) dated July 30, 2019, and (Case #628182) dated March 18, 2022. Based on our evaluation, it appears that you have adequately addressed the violations contained in these warning letters. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Ronda Loyd-Jones Director, Compliance Branch Office of Pharmaceutical Quality Operations, Division II Content current as of: 10/24/2023 Regulated Product(s) Drugs